Director, Cardiovascular MRI/CT; Director, Clinic Operations
Cardiology
Dr. Christopher K. Dyke, MD
|
|
Give Review
Christopher Dyke practices Cardiology. He went to medical school at University of Texas Southwestern Medical School. He over the years received 1 awards: "Meaningful Use Stage 1 Certification". Christopher Dyke is a published physician as well. He has 21 publications published. The latest was: Pulmonary autograft versus homograft replacement of the aortic valve: a prospective randomized trial.
Publications
- Prevalence and prognosis of unrecognized Myocardial infarction determined by cardiac magnetic resonance in older adults.
- Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable Coronary artery disease.
- Age-related vascular stiffness and left ventricular size after Myocardial infarction.
- First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the c...
- Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain.
- Artifact suppression in imaging of Myocardial infarction using B1-weighted phased-array combined phase-sensitive inversion recovery.
- First experience with direct factor Xa inhibition in patients with stable Coronary disease: a pharmacokinetic and pharmacodynamic evaluation.
- Misreporting of Myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antag...
- Pulmonary autograft versus homograft replacement of the Aortic valve: a prospective randomized trial.
- Inhibitors of the platelet receptor glycoprotein IIb-IIIa and complications during percutaneous Coronary revascularization. Management strategies for the cardiac surgeon.
- Highlights from the XXII congress of the European Society of Cardiology: August 26 to 30, 2000.
- Highlights from the American College of Cardiology 49th Annual Scientific Sessions: March 12 to 15, 2000.
- Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute co...
- Initial experience with factor-Xa inhibition in percutaneous Coronary intervention: the XaNADU-PCI Pilot.
- First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation Acute coronary syndromes: results of the XaNADU-ACS Trial.
- Enhanced efficacy of eptifibatide administration in patients with Acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators.
- Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic Coronary artery disease.
- The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiba...
- Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist.
- Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular Disease.
Schools
University of Texas Southwestern Medical Center At Dallas
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
National Institutes of Health Clinical Center -
Duke University Hospital -
University of Texas Southwestern Medical School
Drug Facts
| NPI NUMBER | 1891704409 | |
| NPPES Provider LastName | DYKE | |
| NPPES Provider FirstName | CHRISTOPHER | |
| NPPES Provider ZIPCode | 99508 | |
| NPPES Provider State | AK | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1125.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891704409 |
| Last Name Of The Provider | DYKE |
| First Name Of The Provider | CHRISTOPHER |
| View All |
Similar Doctors
|
|
Dr. Stanley P. Watkins III, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William P. Mayer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seth L. Krauss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan E. Skolnick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven J. Compton, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Peter M. Sapin, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. William A. Kutchera, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda A. Ireland, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Anschuetz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam C. Mason, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ankie M. Amos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas K. Kramer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa N. Gray, DO
This Doctor is OpenDoctor Recommended.
|